The system, designed by Stanford researchers, identified which drugs are more likely to succeed in trials and even proposed a cancer treatment a major drugmaker later landed on too. The post Virtual Biotech Company Puts 37,000 AI Agents to Work on Drug Discovery appeared first on SingularityHub.